# FDA WARNING_LETTER - Cdymax (India) Pharma Private Limited - April 25, 2025

Source: https://www.globalkeysolutions.net/records/warning_letter/cdymax-india-pharma-private-limited/5483d583-5418-4d4b-8801-ace48e9e8d53

> FDA WARNING_LETTER for Cdymax (India) Pharma Private Limited on April 25, 2025. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Cdymax (India) Pharma Private Limited
- Inspection Date: 2025-04-25
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2025-04-21](https://www.globalkeysolutions.net/records/483/cdymax-india-pharma-private-limited/825aaba7-c785-40b6-86dd-10a04b320712)
- [483 - 2025-04-21](https://www.globalkeysolutions.net/records/483/cdymax-india-pharma-private-limited/a0671733-5d61-4c87-b228-813b77f4c899)
- [483 - 2025-04-25](https://www.globalkeysolutions.net/records/483/cdymax-india-pharma-private-limited/641b5486-25db-437a-8a02-5301581a97c0)

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)

Company: https://www.globalkeysolutions.net/companies/cdymax-india-pharma-private-limited/51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c